TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q1 2024 vs. Q4 2023
How the institutions holding TriSalus Life Sciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 19 | 25 | +6 |
| Shares | 679.6K | 926.0K | +246.4K (+36.3%) |
| Value | $5.74M | $9.03M | +$3.29M (+57.2%) |
New holders (9)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 315,955 | $3.08M | 0.08% |
| Goldman Sachs Group Inc | 54,475 | $531.1K | 0.00% |
| Millennium Management LLC | 17,696 | $172.5K | 0.00% |
| JPMorgan Chase & Co | 10,559 | $103.0K | 0.00% |
| Qube Research & Technologies Ltd | 5,490 | $53.5K | 0.00% |
| Bank of America Corp | 2,168 | $21.1K | 0.00% |
| Signaturefd, LLC | 100 | $975 | 0.00% |
| Clear Street LLC | 1 | $10 | 0.00% |
| Macquarie Group Ltd | 291 | $3 | 0.00% |
Sold out (3)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| HC Advisors, LLC | 101,736 | $859.7K |
| HRT Financial LP | 48,011 | $405.0K |
| Creative Planning | 16,216 | $137.0K |